Evidence map›Paper›PMID 22442320›Full record

ArticleJournal of clinical microbiology2012

A multidrug-resistant Staphylococcus epidermidis clone (ST2) is an ongoing cause of hospital-acquired infection in a Western Australian hospital.

Micael Widerström, Cheryll A McCullough, Geoffrey W Coombs, Tor Monsen, Keryn J Christiansen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. mBio · 2024
    Article
  3. Article
  4. Article
  5. Heterogeneity of Staphylococcus epidermidis in prosthetic joint infections: time to reevaluate microbiological criteria?European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
  6. Characterization ofPeerJ · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A Novel, WidespreadAntimicrobial agents and chemotherapy · 2019
    Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Heterogeneous glycopeptide intermediate Staphylococcus epidermidis isolated from prosthetic joint infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Micael WiderströmDepartment of Clinical Bacteriology, Umeå University, Umeå, Sweden. mikael.widerstrom@jll.se
Cheryll A McCullough
Geoffrey W Coombs
Tor Monsen
Keryn J Christiansen
Royal Perth Hospital · AUUmeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the molecular epidemiology of 27 clinical multidrug-resistant Staphylococcus epidermidis (MDRSE) isolates collected between 2003 and 2007 in an Australian teaching hospital. The dominant genotype (sequence type 2 [ST2]) accounted for 85% of the isolates tested and was indistinguishable from an MDRSE genotype identified in European hospitals, which may indicate that highly adaptable health care-associated genotypes of S. epidermidis have emerged and disseminated worldwide in the health care setting.

Indexed as

Drug Resistance, Multiple, BacterialAdultAgedAged, 80 and overCluster AnalysisCross InfectionElectrophoresis, Gel, Pulsed-FieldFemaleGenotypeHospitals, TeachingHumansMaleMiddle AgedMolecular EpidemiologyMolecular TypingStaphylococcal Infections

Identifiers

PMID22442320
PMCPMC3372155
OpenAlexW2030529989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.